Investor Fwhc Holdings, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Fwhc Holdings, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-06 13D/A IVRN / Innoveren Scientific Inc. 697,273 0
2024-02-06 13D/A IVRN / Innoveren Scientific Inc. 697,273
2022-02-25 13D/A HCYT / H-CYTE Inc 654,961,013 697,263,374
2021-03-11 13D/A HCYT / H-CYTE Inc 673,520,735 654,961,013
2020-10-01 13D/A HCYT / H-CYTE Inc 649,265,447 673,520,735
2020-07-10 13D/A HCYT / H-CYTE Inc 29,339,514 649,265,447
2020-05-20 13D/A HCYT / H-CYTE Inc 29,339,514 29,339,514
2020-02-25 13D HCYT / H-CYTE Inc 29,339,514